Zufika Qamar
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part II: polymeric nanocarriers for combination therapy and advanced targeting.
Journal: Expert opinion on drug delivery
Published: October 22, 2025
Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part I: receptor-mediated nose-to-brain delivery approaches for glioblastoma.
Journal: Expert opinion on drug delivery
Published: October 21, 2025
Intranasal Delivery of Ligand-Conjugated NLCs Co-Loaded With Docetaxel and Quercetin: HPLC Method Development, Pharmacokinetics, and Brain Biodistribution in Wistar Rats for Glioblastoma.
Journal: Biomedical chromatography : BMC
Published: July 02, 2025
Nose to brain delivery of nanostructured lipid carriers loaded with rivastigmine and nilotinib for treating Alzheimer's disease: preparation, cell line study, and in vivo evaluation.
Journal: Discover nano
Published: November 20, 2024
Prospective Utilization of Nanocarriers Loaded with Drug Combination for Treating Alzheimer's Disease.
Journal: Current pharmaceutical design
Published: August 05, 2024
Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells.
Journal: Journal of drug targeting
Published: August 01, 2023
Thymoquinone-Enriched Naringenin-Loaded Nanostructured Lipid Carrier for Brain Delivery via Nasal Route: In Vitro Prospect and In Vivo Therapeutic Efficacy for the Treatment of Depression.
Journal: Pharmaceutics
Published: January 31, 2022
Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations.
Journal: Polymers
Published: November 22, 2021
An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor.
Journal: Frontiers in bioengineering and biotechnology
Published: October 04, 2021
Lipid nanocarrier of selegiline augmented anti-Parkinson's effect via P-gp modulation using quercetin.
Journal: International journal of pharmaceutics
Published: June 24, 2021
Ligand Conjugated Targeted Nanotherapeutics for Treatment of Neurological Disorders.
Journal: Current pharmaceutical design
Published: November 16, 2019
Orally Administered Nanotherapeutics For Parkinson's Disease: An Old Delivery System Yet More Acceptable.
Journal: Current pharmaceutical design
Published: November 16, 2019
Last Updated: 09/26/2026